Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 2-year efficacy and safety results from the GATHER2 phase 3 trial.
Ophthalmology
View this publicationOphthalmology
View this publicationJournal of cardiothoracic and vascular anesthesia
View this publicationDermatology and therapy
View this publicationClinical immunology (Orlando, Fla.)
View this publicationOphthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde
View this publicationImmunity
View this publicationBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
View this publicationNature communications
View this publicationJAMA
View this publicationTrends in immunology
View this publication